Ergomed provides specialist services to the pharmaceutical industry spanning all phases of clinical development and medical information.
Ergomed plc - Trading Update
+Total revenue growth of 38.8% over H1 2020 to £56.0 million (up 48.1% in constant currency*)
+CRO division delivered strong growth with revenue up 90.7% over H1 2020 to £27.2 million, including the MedSource business acquired in 2020, with like-for-like growth of 16.1% (24.5% in constant currency)